VP, Psychiatric Excellence & Emerging Therapeutics

LifeStance Health

About The Position

This role is responsible for co-developing enterprise psychiatric strategy with the Chief Medical Officer (CMO) to define, advance, and operationalize psychiatric excellence, specialty service lines, and emerging therapeutics. The role translates clinical evidence, outcomes research, and best practices into scalable, standardized psychiatric care models and innovation frameworks that drive quality, safety, and measurable outcomes across the organization. Success in this role is demonstrated through the establishment of enterprise clinical standards, improved patient outcomes, and the responsible scaling of specialty and emerging therapeutic programs (e.g., interventional psychiatry, TMS, ketamine, other neuromodulation techniques, and digital therapeutics). The role serves psychiatrists, clinical operations teams, patients, and executive leadership by ensuring consistent, high-quality psychiatric care and advancing the organization’s clinical differentiation and long-term strategy.

Requirements

MD or DO (required)
Board Certification in Psychiatry (required upon hire)
12+ years of functional psychiatric experience
10+ years of supervisory experience
8+ years of leadership experience
Deep clinical expertise in psychiatric practice, including psychopharmacology, specialty and interventional psychiatry (e.g., TMS, ketamine, neuromodulation), and emerging therapeutic modalities
Strong experience translating clinical evidence and outcomes data into scalable care models, standards, and protocols
Demonstrated ability to operate within complex healthcare environments, including governance, regulatory, and compliance frameworks
Proven ability to lead enterprise-level clinical initiatives, drive standardization, and improve quality and outcomes

Nice To Haves

15+ years of functional and/or industry experience
15+ years of supervisory experience
Advanced experience leading large-scale clinical transformation initiatives, including Centers of Excellence or specialty program development
Experience partnering with research teams to incorporate outcomes data and clinical evidence into strategy and innovation
Demonstrated success influencing executive leadership and driving cross-functional alignment in a matrixed healthcare organization
Experience in scaling emerging therapeutic programs within a clinically governed, regulated environment

Responsibilities

Lead the development and execution of enterprise psychiatric excellence and emerging therapeutics strategy in partnership with the CMO, aligning with organizational goals and clinical priorities.
Establish and govern enterprise psychiatric standards, clinical protocols, and care models to ensure quality, safety, consistency, and scalability across general and specialty settings.
Develop and scale Psychiatric Centers of Excellence to drive clinical differentiation, improved outcomes, and readiness for value-based care models.
Translate clinical research, outcomes data, and emerging evidence into actionable strategies, care pathways, and innovation initiatives that enhance patient outcomes and operational effectiveness.
Oversee specialty and interventional psychiatric programs (e.g., psychopharmacology, TMS, ketamine, neuromodulation), ensuring evidence-based design, clinical integrity, and scalable implementation.
Drive cross-functional implementation and governance by partnering with Clinical Operations, Operations, Learning & Development, Legal, Compliance, and Research to embed standards and therapies into workflows.
Lead and develop high-performing psychiatric leadership teams, fostering accountability, collaboration, and alignment with enterprise clinical strategy.
Influence a broad network of clinical and operational leaders to align on strategy, standards, and execution.
Ensure regulatory compliance and clinical governance by overseeing adherence to legal, accreditation, and safety requirements, and approving risk mitigation plans for psychiatric programs.
Partner with CMO to oversee Clinical Governance committees.